Sabra Health Care REIT, Inc. (SBRA) Upgraded to Buy at Truist Securities

Market Context

Sabra Health Care REIT, Inc. operates in the Real Estate sector. The stock currently trades at $20.09 with a market capitalization of $4.5B.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Truist Securities's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Sabra Health Care REIT, Inc.

Among the 10 most recent ratings: 3 Buy, 6 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 08, 2026	Truist Securities	Buy	N/A
Jul 07, 2026	Barclays	Equal-Weight	N/A
Jun 23, 2026	Citigroup	Neutral	N/A
Jun 18, 2026	Scotiabank	Sector Perform	N/A
Jun 17, 2026	Raymond James	Underperform	N/A

Related Tools: Analyst Ratings Dashboard | View SBRA Stock Page